Achieve Life Sciences (ACHV) Q1 2026 Annual Earnings
ACHV·Reported May 12, 2026·Before market open
Diluted EPS came in at $-0.19 (+48.6% YoY), beat the $-0.30 consensus by $0.11.
Diluted EPS
$-0.19beat by $0.11
Consensus: $-0.30
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Achieve Life Sciences's Q1 2026 earnings report.
Achieve Life Sciences (ACHV) reported Q1 2026 earnings on May 12, 2026 before market open.
Achieve Life Sciences reported diluted EPS of $-0.19 for Q1 2026.
EPS beat the consensus estimate of $-0.30 by $0.11.
Compared to the same quarter a year prior, diluted EPS grew 48.6% from $-0.37.
You can read the 8-K earnings release (0001193125-26-218175) and the 10-K/A periodic report (0001193125-26-197402) directly on SEC EDGAR. The filing index links above go to sec.gov.